Literature DB >> 15456743

Interaction of calcium-bound C-reactive protein with fibronectin is controlled by pH: in vivo implications.

Madathilparambil V Suresh1, Sanjay K Singh, Alok Agrawal.   

Abstract

C-reactive protein (CRP) binds with high affinity to fibronectin (Fn), a major component of the extracellular matrix (ECM), but at physiological pH the binding is inhibited by calcium ions (Ca2+). Because CRP circulates in the blood in Ca2+ -bound form, the occurrence of CRP-Fn interactions in vivo has been doubtful. To define the basis of inhibition of CRP-Fn interaction by Ca2+ at pH 7.0, we hypothesized that Fn-binding site on CRP consisted of amino acids co-ordinating Ca2+. Site-directed mutagenesis of amino acids co-ordinating Ca2+ drastically decreased the binding of CRP to Fn, indicating that the Ca2+ -binding site indeed formed the Fn-binding site. To determine the requirements for possible interaction between Ca2+ -bound CRP and Fn, we investigated inhibition of CRP-Fn interaction by Ca2+ as a function of pH. Ca2+ did not inhibit binding of CRP to Fn at pH 6.5 and lower. The contrasting Fn binding properties of CRP at physiological and mildly acidic pH indicated that the interaction of Ca2+ -bound CRP with Fn was controlled by pH. We conclude that the inhibition of binding of CRP to Fn by Ca2+ at pH 7.0 is a mechanism to prevent CRP-Fn interactions under normal conditions. CRP, in its Ca2+ -bound state, is capable of binding Fn but only at the inflammatory sites and tumors with low pH. CRP, Fn, and the ECM all have been implicated in cancer. Taken together our data raise the possibility that CRP-Fn interactions may change the architecture of ECM to modify the development of tumors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15456743      PMCID: PMC3819716          DOI: 10.1074/jbc.M409054200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

Review 1.  A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cells.

Authors:  C E Hack; G J Wolbink; C Schalkwijk; H Speijer; W T Hermens; H van den Bosch
Journal:  Immunol Today       Date:  1997-03

2.  Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins).

Authors:  A P Osmand; B Friedenson; H Gewurz; R H Painter; T Hofmann; E Shelton
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

Review 3.  Fibronectin and its integrin receptors in cancer.

Authors:  E Ruoslahti
Journal:  Adv Cancer Res       Date:  1999       Impact factor: 6.242

Review 4.  Human C-reactive protein: expression, structure, and function.

Authors:  J E Volanakis
Journal:  Mol Immunol       Date:  2001-08       Impact factor: 4.407

5.  C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids.

Authors:  Mi-Kyung Chang; Christoph J Binder; Michael Torzewski; Joseph L Witztum
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-20       Impact factor: 11.205

6.  Deletion of the alternatively spliced fibronectin EIIIA domain in mice reduces atherosclerosis.

Authors:  Michelle H Tan; Zhengwu Sun; Sarah L Opitz; Tracy E Schmidt; John H Peters; Elizabeth L George
Journal:  Blood       Date:  2004-02-19       Impact factor: 22.113

Review 7.  The relevance of tumour pH to the treatment of malignant disease.

Authors:  J L Wike-Hooley; J Haveman; H S Reinhold
Journal:  Radiother Oncol       Date:  1984-12       Impact factor: 6.280

8.  The phosphocholine and the polycation-binding sites on rabbit C-reactive protein are structurally and functionally distinct.

Authors:  Steven Black; Alok Agrawal; David Samols
Journal:  Mol Immunol       Date:  2003-06       Impact factor: 4.407

9.  Effects on C-reactive protein on the lymphoid system. I. Binding to thymus-dependent lymphocytes and alteration of their functions.

Authors:  R F Mortensen; A P Osmand; H Gewurz
Journal:  J Exp Med       Date:  1975-04-01       Impact factor: 14.307

10.  Studies of acute phase protein. I. An immunohistochemical method for the localization of Cx-reactive protein in rabbits. Association with necrosis in local inflammatory lesions.

Authors:  I KUSHNER; M H KAPLAN
Journal:  J Exp Med       Date:  1961-12-01       Impact factor: 14.307

View more
  29 in total

1.  Regulation of basal and induced expression of C-reactive protein through an overlapping element for OCT-1 and NF-kappaB on the proximal promoter.

Authors:  Bhavya Voleti; Alok Agrawal
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

2.  Human C-reactive protein protects mice from Streptococcus pneumoniae infection without binding to pneumococcal C-polysaccharide.

Authors:  Madathilparambil V Suresh; Sanjay K Singh; Donald A Ferguson; Alok Agrawal
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

3.  Binding of the monomeric form of C-reactive protein to enzymatically-modified low-density lipoprotein: effects of phosphoethanolamine.

Authors:  Sanjay K Singh; Madathilparambil V Suresh; David J Hammond; Antonio E Rusiñol; Lawrence A Potempa; Alok Agrawal
Journal:  Clin Chim Acta       Date:  2009-06-21       Impact factor: 3.786

4.  Functional Transformation of C-reactive Protein by Hydrogen Peroxide.

Authors:  Sanjay K Singh; Avinash Thirumalai; Asmita Pathak; Donald N Ngwa; Alok Agrawal
Journal:  J Biol Chem       Date:  2017-01-17       Impact factor: 5.157

5.  Differences in the Impact of Pneumococcal Serotype Replacement in Individuals With and Without Underlying Medical Conditions.

Authors:  Daniel M Weinberger; Joshua L Warren; Tine Dalby; Eugene D Shapiro; Palle Valentiner-Branth; Hans-Christian Slotved; Zitta Barrella Harboe
Journal:  Clin Infect Dis       Date:  2019-06-18       Impact factor: 9.079

Review 6.  The protective function of human C-reactive protein in mouse models of Streptococcus pneumoniae infection.

Authors:  Alok Agrawal; Madathilparambil V Suresh; Sanjay K Singh; Donald A Ferguson
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-12       Impact factor: 2.895

Review 7.  The connection between C-reactive protein and atherosclerosis.

Authors:  Sanjay K Singh; Madathilparambil V Suresh; Bhavya Voleti; Alok Agrawal
Journal:  Ann Med       Date:  2008       Impact factor: 4.709

8.  Role of the property of C-reactive protein to activate the classical pathway of complement in protecting mice from pneumococcal infection.

Authors:  Madathilparambil V Suresh; Sanjay K Singh; Donald A Ferguson; Alok Agrawal
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

9.  Genomic regions that influence plasma levels of inflammatory markers in hypertensive sibships.

Authors:  K Ding; D Feng; M de Andrade; T H Mosley; S T Turner; E Boerwinkle; I J Kullo
Journal:  J Hum Hypertens       Date:  2007-10-25       Impact factor: 3.012

10.  Probing the phosphocholine-binding site of human C-reactive protein by site-directed mutagenesis.

Authors:  A Agrawal; Y Xu; D Ansardi; K J Macon; J E Volanakis
Journal:  J Biol Chem       Date:  1992-12-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.